Immunomodulators in SLE: Clinical evidence and immunologic actions

Por Durcan, L., Petri, M.
Publicado no J Autoimmun (2016)

Prospective Study of Outcome in Sporadic versus Hereditary Breast Cancer: pros and cons of running a cohort study

Por Gerty, SM, Simmonds, PD, Durcan, L, Eccles, DM
Publicado em 2008

An evaluation of the prognostic model PREDICT using the POSH cohort of women aged ⩽40 years at breast cancer diagnosis

Por Maishman, T, Copson, E, Stanton, L, Gerty, S, Dicks, E, Durcan, L, Wishart, G C, Pharoah, P, Eccles, D
Publicado no Br J Cancer (2015)

Ethnicity and outcome of young breast cancer patients in the United Kingdom: the POSH study

Por Copson, E, Maishman, T, Gerty, S, Eccles, B, Stanton, L, Cutress, R I, Altman, D G, Durcan, L, Simmonds, P, Jones, L, Tapper, W, Eccles, Diana
Publicado em 2014

A novel tumour-based test to identify breast cancer due to BRCA1 and BRCA2 mutations

Por An, Q, Jones, L, Tapper, W, Chelala, C, Iravani, M, MacKay, A, Hammond, V, Durcan, L, Gerty, S, Ferguson, A, Strefford, J, Peock, S, Reis-Filho, J, Easton, D, Ashworth, A, Eccles, D
Publicado em 2010